FGF21 and glucose measurement: GCGR mAb significantly lowered fasting blood glucose levels and improved glucose tolerance in db/db mice but the glucose-lowering effect was not abolished by adding FGF21 nAb (Fig. 5b,c), suggesting that FGF21 does not participate in the GCGR mAb-induced hypoglycaemic effect.